Dr. Rachel N. Grisham presented findings at the 2026 Society of Gynecologic Oncology Annual Meeting showing that the ...
SurvivorNet on MSN
'Very promising': New cancer drug, Plixorafenib, shows promise for hard‑to‑treat brain tumors as FDA speeds its development
The U.S. Food and Drug Administration (FDA) has granted plixorafenib a Breakthrough Therapy Designation, signaling ...
The text hit Mark Byington’s phone on a Wednesday night in late January, the day after Vanderbilt beat Kentucky at Memorial Gym by 25 points while B ...
Leah Phillips never smoked and doctors thought her symptoms were due to a cold or allergies. Given a terminal lung cancer ...
A new study co-led by the Institute for Systems Biology (ISB) shows that some lung cancers can change identity as they evolve ...
Cancer is a complex disease that develops when cells in the body grow out of control. For many years, scientists have tried to understand exactly how normal cells turn into cancer cells. We already ...
Researchers found strong genetic similarities between cat and human cancers, identifying key mutations and potential ...
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will present new research at the American Association for Cancer Research (AACR) Annual Meeting, highlighting ...
Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in ...
Aspirin reduces the risk for colorectal cancer in high-risk groups, such as Lynch syndrome, but shows no benefit in the ...
Mutations in a protein called KRAS fuel some of the most lethal cancers. Designing drugs to disable KRAS has proved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results